This diversified cannabis pioneer could make huge moves soon

The cannabis industry seems deeply saturated, so how do you know where to best invest your money? Let’s start with diversification and experience. Founded in 2005, this company serves a diverse and expansive customer base with more than 8,000 retail locations, including licensed cannabis dispensaries, smoke shops, and specialty retailers.

Ann Rhoads Biography and Net Worth

Director of Globus Medical

Ann D. Rhoads has served on our Board of Directors since July 2011, and is a member of our Audit Committee and our Nominating and Corporate Governance Committee. Ms. Rhoads currently serves as Chief Financial Officer of Forty Seven, Inc.(NASDAQ: FTSV), a clinical-stage biotechnology company focused on developing checkpoint therapies to activate macrophages in the fight against cancer. Previously, Ms. Rhoads was Executive Vice President and Chief Financial Officer of Zogenix, Inc. (NASDAQ:ZGNX), a pharmaceutical company, from March 2010 through January 2017.

From 2000 through the end of 2009, Ms. Rhoads served as the Chief Financial Officer of Premier, Inc., a healthcare supply management company. Ms. Rhoads holds a B.S. in Finance from the University of Arkansas and an M.B.A. from the Harvard Business School. Ms. Rhoads also serves on the Board of Directors, as chairperson of the audit committee and as a member of the compensation committee of Evoke Pharma, Inc. (NASDAQ: EVOK). Ms. Rhoads also previously served on the Board of Directors of Iridex Corporation (NASDAQ: IRIX) from 2017 to 2018 and Novellus Systems, Inc. (NASDAQ: NVLS) from 2003 until 2012.

Ms. Rhoads’ experience as the chief financial officer of publicly-traded biotechnology and pharmaceutical companies brings valuable financial skills and expertise to our Board of Directors that includes significant executive management experience and leadership skills, and a strong understanding of corporate governance principles.

What is Ann D. Rhoads' net worth?: The estimated net worth of Ann D. Rhoads is at least $3.03 million as of September 13th, 2024. Ms. Rhoads owns 42,884 shares of Globus Medical stock worth more than $3,027,610 as of September 19th. This net worth estimate does not reflect any other assets that Ms. Rhoads may own. Learn More about Ann D. Rhoads' net worth.
How do I contact Ann D. Rhoads?: The corporate mailing address for Ms. Rhoads and other Globus Medical executives is 2560 GENERAL ARMISTEAD AVENUE, AUDUBON PA, 19403. Globus Medical can also be reached via phone at (610) 930-1800 and via email at [email protected]. Learn More on Ann D. Rhoads' contact information.
Has Ann D. Rhoads been buying or selling shares of Globus Medical?: Over the course of the past ninety days, Ann D. Rhoads has sold $1,055,400.00 in shares of Globus Medical stock. Most recently, Ann D. Rhoads sold 15,000 shares of the business's stock in a transaction on Friday, September 13th. The shares were sold at an average price of $70.36, for a transaction totalling $1,055,400.00. Following the completion of the sale, the director now directly owns 42,884 shares of the company's stock, valued at $3,017,318.24. Learn More on Ann D. Rhoads' trading history.
Who are Globus Medical's active insiders?: Globus Medical's insider roster includes David Davidar (Director), David Demski (CEO), Robert Douglas (Director), Kelly Huller (SVP), Dan Lemaitre (Director), Leslie Norwalk (Director), Keith Pfeil (CFO), Ann Rhoads (Director), Daniel Scavilla (EVP), and James Tobin (Director). Learn More on Globus Medical's active insiders.
Are insiders buying or selling shares of Globus Medical?: During the last year, insiders at the medical device company sold shares 5 times. They sold a total of 109,890 shares worth more than $7,065,787.10. The most recent insider tranaction occured on September, 13th when Director Ann D Rhoads sold 15,000 shares worth more than $1,055,400.00. Insiders at Globus Medical own 18.5% of the company. Learn More about insider trades at Globus Medical.
Information on this page was last updated on 9/13/2024.

Ann D. Rhoads Insider Trading History at Globus Medical

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
9/13/2024	Sell	15,000	$70.36	$1,055,400.00	42,884

Ann D. Rhoads Buying and Selling Activity at Globus Medical

Globus Medical Company Overview

Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative and congenital conditions, deformity, tumors, and trauma injuries; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. It also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, the company distributes human cell, tissue, and cellular and tissue-based products. It sells its products through direct or distributor sales representatives, as well as hip and knee products through independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.

Today's Range

Now: $70.60

$69.35

$70.99

50 Day Range

MA: $70.89

$67.08

$73.93

2 Week Range

Now: $70.60

$43.38

$74.21

Volume

592,677 shs

Average Volume

1,035,403 shs

Market Capitalization

$9.56 billion

P/E Ratio

110.31

Dividend Yield

N/A

Beta

1.17

This diversified cannabis pioneer could make huge moves soon

From Greenlane | Ad

Learn more here.